Connect with us

Daily News

South Africa’s Life Healthcare Not Ruling Out Return to India After Max Disposal

South African private hospital group Life Healthcare has said it is not ruling out a return to India after selling the firm’s entire stake in Max Healthcare, in an effort to focus on its operations elsewhere. The hospital group said on Wednesday it will sell its entire 49.7 percent stake in India’s Max Healthcare to global investment firm KKR & Co. L.P. for 4.3 billion rand (USD 293 million). “In the long-term, India is still a very exciting healthcare environment. South Africa is still a strategic focus for us and Europe, given the significant investments we have made there in recent years,” Chief Executive Shrey Viranna told Reuters. “Max was a good investment with a strong management team but it was more about our strategy.” Max Healthcare has also been grappling with regulatory changes in India over the past year, he said. Indian authorities proposed capping medical costs at private hospitals in the capital to help millions of people, but the plan would deal a blow to the multi-billion-dollar healthcare sector already grappling with price control policies.

In the six-months to the end of March 32, Max Healthcare reported a wider loss of 67 million rand compared with a loss of 12 million in 2017, negatively impacted by the increased regulatory environment and the loss of its license at Max Shalimar Bagh hospital over a case of medical negligence. Following the disposal, Life Healthcare wants to focus its attention on its core operations in South Africa, UK, Poland and Western Europe. The company, whose local competitors include Netcare and Mediclinic has diversified geographically and has also started offering new services. In 2016 it entered the diagnostic imaging market through the acquisition of UK-based Alliance Medical Group, which also operates in Ireland, Italy, Spain, and Northern Europe. Viranna said the group will continue to make strategic investments in its existing markets, without giving any details. “We will absolutely look to invest for growth where it makes good financial sense for us. We will look to invest very selectively in our existing geographies as opposed to adding new ones,” he added. – Business Standard

Copyright © 2024 Medical Buyer

error: Content is protected !!